Hybrid Conferencee

International Conference on Cancer Genetics and Molecular Oncology (ICCGMO - 27)

9th - 10th January 2027 | Glasgow, UK
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Glasgow. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Glasgow event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Glasgow conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Glasgow, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Glasgow."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Cancer Genomics

This track will explore the latest breakthroughs in cancer genomics, focusing on the identification and characterization of somatic mutations. Discussions will include the implications of genomic profiling for precision oncology and personalized medicine.

Track 02

Oncogenes and Tumor Suppressor Genes

This session will delve into the roles of oncogenes and tumor suppressor genes in cancer development and progression. Researchers will present findings on how these genetic factors contribute to tumorigenesis and therapeutic resistance.

Track 03

Cancer Biomarkers: Discovery and Application

This track will highlight the discovery of novel cancer biomarkers and their applications in early detection and treatment monitoring. Emphasis will be placed on the integration of biomarker research into clinical practice.

Track 04

Epigenetic Alterations in Cancer

This session will focus on the role of epigenetic modifications in cancer biology, including DNA methylation and histone modification patterns. Researchers will discuss how these alterations influence gene expression and tumor behavior.

Track 05

Targeted Therapies in Oncology

This track will examine the development and implementation of targeted therapies in cancer treatment. Presentations will cover the mechanisms of action, efficacy, and challenges associated with these innovative therapeutic approaches.

Track 06

Molecular Diagnostics in Cancer Care

This session will address the advancements in molecular diagnostics for cancer, including mutation screening and genomic profiling techniques. The focus will be on how these diagnostics enhance patient stratification and treatment outcomes.

Track 07

Cancer Pathways and Therapeutic Targets

This track will explore the intricate cancer pathways that drive tumorigenesis and metastasis. Discussions will include identifying novel therapeutic targets within these pathways for the development of new treatment strategies.

Track 08

Genomic Instability and Cancer Progression

This session will investigate the mechanisms of genomic instability and its contribution to cancer progression. Researchers will present data on how instability affects tumor evolution and response to therapy.

Track 09

Gene Expression Analysis in Oncology

This track will focus on the methodologies and findings related to gene expression analysis in cancer research. Emphasis will be placed on how gene expression profiles can inform treatment decisions and prognostic outcomes.

Track 10

Translational Oncology: Bridging Research and Practice

This session will highlight the importance of translational research in oncology, showcasing successful case studies that have moved from bench to bedside. Discussions will focus on overcoming barriers to effective translation of research findings into clinical applications.

Track 11

Precision Oncology: Tailoring Treatments to Individuals

This track will explore the principles and practices of precision oncology, emphasizing the need for individualized treatment strategies based on genetic and molecular profiling. Presentations will discuss the challenges and successes in implementing precision medicine in diverse patient populations.